| Tasmar 200 mg film-coated tablets EU/1/97/044/006 |
Tolcapone |
Viatris Healthcare Limited |
— |
| Tauvid 800 MBq/mL solution for injection EU/1/24/1799/001 |
Flortaucipir (18F) |
Eli Lilly Nederland B.V. |
— |
| Tavlesse EU/1/19/1408/001 |
FOSTAMATINIB |
Rigel Pharmaceuticals B.V. |
— |
| Tavlesse EU/1/19/1405/002 |
FOSTAMATINIB |
Instituto Grifols S.A. |
— |
| TAVNEOS 10 mg Capsule, hard EU/1/21/1605/001-002 |
Avacopan |
Vifor Fresenius Medical Care Renal Pharma France |
— |
| Taxotere 20 mg/0.5 ml Concentrate and solvent for solution for infusion EU/1/95/002/001 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 20 mg/1 ml Concentrate and solvent for solution for infusion EU/1/95/002/003 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/2 ml Concentrate and solvent for solution for infusion EU/1/95/002/002 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/4 ml Concentrate and solvent for solution for infusion EU/1/95/002/004 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Tecartus 0.4 – 2 × 108 cells dispersion for infusion EU/1/20/1492/001 |
Autologous Peripheral Blood T Cells CD4 and CD8 selected and CD3 and CD28 Activated Transduced with Retroviral Vectir Expressing Anti CD19 CD28/CD3-Zeta Chimeric Antigen Receptor and Cultured |
Kite Pharma EU B.V. |
— |
| Tecentriq 1200 mg concentrate for solution for infusion EU/1/17/1220/001 |
Atezolizumab |
Roche Registration GmbH |
— |
| Tecentriq 1875 mg solution for injection EU/1/17/1220/003 |
Atezolizumab |
Roche Registration GmbH |
— |
| Tecentriq 840 mg concentrate for solution for infusion EU/1/17/1220/002 |
Atezolizumab |
Roche Registration GmbH |
— |
| Tecfidera 120 mg gastro-resistant hard capsules EU/1/13/837/001 |
Dimethyl Fumarate |
Biogen Netherlands B.V. |
— |
| Tecfidera 240 mg gastro-resistant hard capsules EU/1/13/837/002 |
Dimethyl Fumarate |
Biogen Netherlands B.V. |
— |
| Technescan DMSA 1.2 mg kit for radiopharmaceutical preparation PA0690/011/001 |
Succimer |
Curium Netherlands B.V. |
Marketed |
| TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation PA0690/015/001 |
PENTETIC ACID |
Curium Netherlands B.V. |
Marketed |
| TechneScan HDP 3mg, kit for radiopharmaceutical preparation PA0690/004/001 |
Oxidronate disodium |
Curium Netherlands B.V. |
Marketed |
| Technescan MIBI 1mg kit for radiopharmaceutical preparation PA0690/020/001 |
Tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate |
Curium Netherlands B.V. |
Marketed |
| Technescan PYP 20 mg kit for radiopharmaceutical preparation PA0690/010/001 |
Sodium pyrophosphate decahydrate, Stannous chloride dihydrate |
Curium Netherlands B.V. |
Marketed |
| Tecovirimat SIGA 200 mg hard capsules EU/1/21/1600/001 |
Tecovirimat Monohydrate |
SIGA Technologies Netherlands B.V. |
— |
| TECVAYLI 10 mg/mL solution for injection EU/1/22/1675/001 |
Teclistamab |
Janssen-Cilag International NV |
— |
| TECVAYLI 90 mg/mL solution for injection EU/1/22/1675/002 |
Teclistamab |
Janssen-Cilag International NV |
— |
| Teetha Chamomilla Teething Gel HOA23352/002/001 |
Chamomilla 12c hab |
Pharmaceutical Business Consultants Limited |
Marketed |
| Teetha Teething Granules HOA23352/001/001 |
Chamomilla recutita |
Pharmaceutical Business Consultants Limited |
Marketed |
| Tegsedi 284 mg solution for injection in pre-filled syringe EU/1/18/1296/001-002 |
INOTERSEN |
Akcea Therapeutics Ireland Ltd |
— |
| Teicoplanin Seacross 200 mg powder for solution for injection/infusion or oral solution PA22766/011/001 |
Teicoplanin |
Seacross Pharma (Europe) Limited |
Not marketed |
| Teicoplanin Seacross 400 mg powder for solution for injection/infusion or oral solution PA22766/011/002 |
Teicoplanin |
Seacross Pharma (Europe) Limited |
Not marketed |
| Telmisartan Actavis 20 mg tablets EU/1/10/639/001-010 |
Telmisartan |
Actavis Group hf |
— |
| Telmisartan Actavis 40 mg tablets EU/1/10/639/011-020 |
Telmisartan |
Actavis Group hf |
— |
| Telmisartan Actavis 80 mg tablets EU/1/10/639/021-030 |
Telmisartan |
Actavis Group hf |
— |
| Telmisartan Rowa 20 mg tablets PA0074/078/001 |
Telmisartan |
Rowa Pharmaceuticals Limited, |
Marketed |
| Telmisartan Rowa 40 mg tablets PA0074/078/002 |
Telmisartan |
Rowa Pharmaceuticals Limited, |
Marketed |
| Telmisartan Rowa 80 mg tablets PA0074/078/003 |
Telmisartan |
Rowa Pharmaceuticals Limited, |
Marketed |
| Telmisartan Teva Pharma 20 mg tablets EU/1/11/719/001-020 |
Telmisartan |
Teva B.V. |
— |
| Telmisartan Teva Pharma 40 mg tablets EU/1/11/719/021-040 |
Telmisartan |
Teva B.V. |
— |
| Telmisartan Teva Pharma 80 mg tablets EU/1/11/719/041-060 |
Telmisartan |
Teva B.V. |
— |
| Telmisartan/Hydrochlorothiazide Rowa 40 mg/12.5 mg tablets PA0074/081/001 |
Telmisartan, Hydrochlorothiazide |
Rowa Pharmaceuticals Limited, |
Marketed |
| Telmisartan/Hydrochlorothiazide Rowa 80 mg/12.5 mg tablets PA0074/081/002 |
Telmisartan, Hydrochlorothiazide |
Rowa Pharmaceuticals Limited, |
Marketed |
| Telmisartan/Hydrochlorothiazide Rowa 80 mg/25 mg tablets PA0074/081/003 |
Telmisartan, Hydrochlorothiazide |
Rowa Pharmaceuticals Limited, |
Marketed |
| Temgesic 200 microgram Sublingual Tablets PA23460/001/001 |
Buprenorphine hydrochloride |
Eumedica Pharmaceuticals GmbH |
Not marketed |
| Temgesic 300 micrograms/ml, solution for injection PA23460/001/002 |
Buprenorphine hydrochloride |
Eumedica Pharmaceuticals GmbH |
Not marketed |
| Temodal 2.5 mg/ml powder for solution for infusion EU/1/98/096/023 |
Temozolomide |
Merck Sharp & Dohme BV |
— |
| Temomedac 100 mg hard capsules EU/1/09/605/5-6 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temomedac 140 mg hard capsules EU/1/09/605/7-8 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temomedac 180 mg hard capsules EU/1/09/605/9-10 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temomedac 20 mg hard capsules EU/1/09/605/3-4 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temomedac 250 mg hard capsules EU/1/09/605/11-12 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temomedac 5 mg hard capsules EU/1/09/605/1-2 |
Temozolomide |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| Temozolomide Accord 100 mg hard capsules EU/1/10/615/009-010 |
Temozolomide |
Accord Healthcare S.L.U. |
— |